Correlation Between Enorama Pharma and Serstech
Can any of the company-specific risk be diversified away by investing in both Enorama Pharma and Serstech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enorama Pharma and Serstech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Enorama Pharma AB and Serstech AB, you can compare the effects of market volatilities on Enorama Pharma and Serstech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enorama Pharma with a short position of Serstech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enorama Pharma and Serstech.
Diversification Opportunities for Enorama Pharma and Serstech
0.34 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Enorama and Serstech is 0.34. Overlapping area represents the amount of risk that can be diversified away by holding Enorama Pharma AB and Serstech AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Serstech AB and Enorama Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enorama Pharma AB are associated (or correlated) with Serstech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Serstech AB has no effect on the direction of Enorama Pharma i.e., Enorama Pharma and Serstech go up and down completely randomly.
Pair Corralation between Enorama Pharma and Serstech
Assuming the 90 days trading horizon Enorama Pharma AB is expected to under-perform the Serstech. But the stock apears to be less risky and, when comparing its historical volatility, Enorama Pharma AB is 1.02 times less risky than Serstech. The stock trades about -0.04 of its potential returns per unit of risk. The Serstech AB is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest 103.00 in Serstech AB on August 29, 2024 and sell it today you would earn a total of 11.00 from holding Serstech AB or generate 10.68% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Enorama Pharma AB vs. Serstech AB
Performance |
| Timeline |
| Enorama Pharma AB |
| Serstech AB |
Enorama Pharma and Serstech Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Enorama Pharma and Serstech
The main advantage of trading using opposite Enorama Pharma and Serstech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enorama Pharma position performs unexpectedly, Serstech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Serstech will offset losses from the drop in Serstech's long position.| Enorama Pharma vs. Cantargia AB | Enorama Pharma vs. Enzymatica publ AB | Enorama Pharma vs. Lidds AB | Enorama Pharma vs. BioArctic AB |
| Serstech vs. Enzymatica publ AB | Serstech vs. Polygiene AB | Serstech vs. Sprint Bioscience AB | Serstech vs. XMReality AB |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Complementary Tools
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |